As cancer care professionals who experience the challenges of providing quality cancer care first-hand, ESHOS members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which is why it's so important that our members make their voices heard.
We want to hear from you! If there is a specific piece of legislation you want to know more about, an important resource we're missing, or if you want to get more involved, please contact us!
ESHOS Joins Support Letter for S5299/A1741
Copay assistance programs can give patients access to a lifesaving medication they may otherwise not be able to afford. Copay accumulators make it more challenging for patients to afford their medication. This bill would end the practice of copay accumulators and assist all patients with out-of-pocket expenses. Read support letter.
COVID-19 Clinical Trials Coalition Letter
The Empire State Hematology & Oncology Society (ESHOS) joined in a coalition letter to congressional leadership urging that Congress include the 21st Century Cures 2.0 concept paper, recently released by Representatives Diana DeGette and Fred Upton in upcoming legislation to further address the COVID-19 public health crisis. The letter urges leadership to include policy to provide Medicaid coverage of the routine care costs of clinical trials participation for patients with life-threatening conditions in every state.